Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J KEATING

Showing results (761-770 of 1,115) with videos related to

Pageof 112
Sort By:
Human Genetics|March 7, 2016
Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic riskVinicius Tragante, Folkert W Asselbergs, Daniel I Swerdlow, et al.
British Journal of Haematology|May 15, 2008
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosisYang O Huh, Katherine I-Chun Lin, Francisco Vega, et al.
Clinical Genetics|February 24, 2015
Utility of next-generation sequencing technologies for the efficient genetic resolution of haematological disordersJ Zhang, P Barbaro, Y Guo, et al.
Neuroscience|October 2, 2012
Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cellsD J Keating, M A Winter, K M Hemsley, et al.
Cancer|June 16, 2004
Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemiaApostolia M Tsimberidou, Michael J Keating, Francis J Giles, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarraysLynne V Abruzzo, Jing Wang, Mini Kapoor, et al.
Blood|May 3, 2002
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyMichael J Keating, Ian Flinn, Vinay Jain, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
NKCC1-dependent GABAergic excitation drives synaptic network maturation during early hippocampal developmentCarsten K Pfeffer, Valentin Stein, Damien J Keating, et al.
Cancer|November 21, 2015
β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemiaPhilip A Thompson, Susan M O'Brien, Lianchun Xiao, et al.
Cancer|April 2, 2011
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcomeIssa F Khouri, Roland Bassett, Nancy Poindexter, et al.
Pageof 112

Showing results (761-770 of 1,115) with videos related to

Sort By:
Pageof 112
Human Genetics|March 7, 2016
Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic riskVinicius Tragante, Folkert W Asselbergs, Daniel I Swerdlow, et al.
British Journal of Haematology|May 15, 2008
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosisYang O Huh, Katherine I-Chun Lin, Francisco Vega, et al.
Clinical Genetics|February 24, 2015
Utility of next-generation sequencing technologies for the efficient genetic resolution of haematological disordersJ Zhang, P Barbaro, Y Guo, et al.
Neuroscience|October 2, 2012
Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cellsD J Keating, M A Winter, K M Hemsley, et al.
Cancer|June 16, 2004
Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemiaApostolia M Tsimberidou, Michael J Keating, Francis J Giles, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarraysLynne V Abruzzo, Jing Wang, Mini Kapoor, et al.
Blood|May 3, 2002
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyMichael J Keating, Ian Flinn, Vinay Jain, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2009
NKCC1-dependent GABAergic excitation drives synaptic network maturation during early hippocampal developmentCarsten K Pfeffer, Valentin Stein, Damien J Keating, et al.
Cancer|November 21, 2015
β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemiaPhilip A Thompson, Susan M O'Brien, Lianchun Xiao, et al.
Cancer|April 2, 2011
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcomeIssa F Khouri, Roland Bassett, Nancy Poindexter, et al.
Pageof 112